HAIM
TMO icon

Hunter Associates Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Hunter Associates Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.48M Buy
10,919
+171
+2% +$82.1K 0.63% 39
2026
Q1 		$5.28M Sell
10,748
-186
-2% -$101K 0.7% 32
2025
Q4 		$6.33M Sell
10,934
-350
-3% -$198K 0.85% 27
2025
Q3 		$5.47M Buy
11,284
+84
+0.8% +$39.1K 0.76% 30
2025
Q2 		$4.53M Sell
11,200
-2,204
-16% -$922K 0.67% 32
2025
Q1 		$6.67M Sell
13,404
-444
-3% -$240K 1.03% 25
2024
Q4 		$7.2M Sell
13,848
-206
-1% -$113K 1.1% 20
2024
Q3 		$8.69M Buy
14,054
+334
+2% +$198K 1.35% 16
2024
Q2 		$7.59M Buy
13,720
+155
+1% +$88.8K 1.28% 18
2024
Q1 		$7.88M Sell
13,565
-150
-1% -$84.2K 1.33% 18
2023
Q4 		$7.28M Buy
13,715
+62
+0.5% +$30K 1.33% 18
2023
Q3 		$6.91M Sell
13,653
-258
-2% -$137K 1.41% 17
2023
Q2 		$7.25M Sell
13,911
-719
-5% -$388K 1.42% 17
2023
Q1 		$8.43M Sell
14,630
-325
-2% -$183K 1.81% 12
2022
Q4 		$8.25M Buy
14,955
+1
+0% +$530 1.99% 9
2022
Q3 		$7.6M Buy
14,954
+131
+0.9% +$73.3K 1.97% 9
2022
Q2 		$8.06M Buy
14,823
+9,673
+188% +$5.32M 1.99% 12
2022
Q1 		$3.04M Sell
5,150
-2,400
-32% -$1.38M 0.98% 25
2021
Q4 		$5.04M Buy
7,550
+1,600
+27% +$999K 1.44% 18
2021
Q3 		$3.4M Buy
5,950
+1,000
+20% +$549K 1.09% 24
2021
Q2 		$2.5M Sell
4,950
-10,457
-68% -$4.93M 0.78% 33
2021
Q1 		$7.03M Buy
15,407
+300
+2% +$143K 1.63% 15
2020
Q4 		$7.04M Buy
15,107
+561
+4% +$263K 1.73% 15
2020
Q3 		$6.42M Sell
14,546
-543
-4% -$224K 1.78% 14
2020
Q2 		$5.47M Buy
15,089
+1,512
+11% +$507K 1.62% 20
2020
Q1 		$3.85M Buy
13,577
+215
+2% +$67.8K 1.49% 20
2019
Q4 		$4.34M Buy
13,362
+110
+0.8% +$33.4K 1.35% 21
2019
Q3 		$3.86M Sell
13,252
-193
-1% -$55.3K 1.33% 20
2019
Q2 		$3.95M Buy
13,445
+33
+0.2% +$9.09K 1.36% 20
2019
Q1 		$3.67M Buy
13,412
+280
+2% +$69.7K 1.29% 20
2018
Q4 		$2.94M Sell
13,132
-100
-0.8% -$23.5K 1.2% 20
2018
Q3 		$3.23M Buy
13,232
+763
+6% +$176K 1.11% 23
2018
Q2 		$2.58M Sell
12,469
-732
-6% -$155K 0.93% 30
2018
Q1 		$2.73M Buy
13,201
+199
+2% +$41.8K 1.02% 30
2017
Q4 		$2.47M Buy
13,002
+821
+7% +$157K 0.91% 31
2017
Q3 		$2.31M Buy
12,181
+148
+1% +$26.8K 0.9% 31
2017
Q2 		$2.1M Buy
12,033
+3
+0% +$504 0.85% 34
2017
Q1 		$1.85M Buy
12,030
+415
+4% +$63.4K 0.78% 36
2016
Q4 		$1.64M Sell
11,615
-320
-3% -$47.2K 0.7% 40
2016
Q3 		$1.9M Sell
11,935
-195
-2% -$30K 0.82% 36
2016
Q2 		$1.79M Sell
12,130
-230
-2% -$33.9K 0.78% 36
2016
Q1 		$1.75M Hold
12,360
– – 0.8% 35
2015
Q4 		$1.75M Sell
12,360
-35
-0.3% -$4.67K 0.77% 33
2015
Q3 		$1.52M Sell
12,395
-150
-1% -$19.5K 0.71% 38
2015
Q2 		$1.63M Hold
12,545
– – 0.68% 41
2015
Q1 		$1.69M Buy
12,545
+105
+0.8% +$13.5K 0.66% 40
2014
Q4 		$1.56M Buy
12,440
+2,205
+22% +$268K 0.6% 41
2014
Q3 		$1.25M Sell
10,235
-250
-2% -$30.4K 0.49% 53
2014
Q2 		$1.24M Sell
10,485
-775
-7% -$91.2K 0.49% 53
2014
Q1 		$1.35M Sell
11,260
-2,000
-15% -$238K 0.53% 44
2013
Q4 		$1.48M Sell
13,260
-1,840
-12% -$183K 0.57% 43
2013
Q3 		$1.39M Sell
15,100
-1,900
-11% -$172K 0.58% 44
2013
Q2 		$1.44M Buy
+17,000
New +$1.42M 0.53% 49

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Hunter Associates Investment Management's TMO Position: Q2 2026 in Review

Hunter Associates Investment Management increased its Thermo Fisher Scientific (TMO) stake by 1.6% in Q2 2026, buying an estimated $82.1K and bringing the position to 10,919 shares worth $5.48M. The position accounts for 0.63% of the portfolio, ranked #39.

Hunter Associates Investment Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.69M in Q3 2024. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Hunter Associates Investment Management held 10,919 shares of Thermo Fisher Scientific worth $5.48M as of Q2 2026.
  • Hunter Associates Investment Management bought 171 Thermo Fisher Scientific shares in Q2 2026, an estimated $82.1K.
  • Thermo Fisher Scientific made up 0.63% of Hunter Associates Investment Management's portfolio in Q2 2026, its #39 holding.
  • Hunter Associates Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Hunter Associates Investment Management's Thermo Fisher Scientific position peaked at $8.69M in Q3 2024.
  • 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.